This webinar will explore the rationale behind the National Bowel Cancer Screening Program's mail-out model and the alternative access to kits model. Participants will learn the benefits of engaging patients in population screening through this alternative model and discover effective methods for doing so. The webinar will also cover how to use the National Cancer Screening Register (NCSR) to bulk order kits and distribute them to patients efficiently. Additionally, attendees will gain insights into changing their practices to apply knowledge of the alternative access to kits model, ultimately increasing patient participation in the National Bowel Cancer Screening Program. This comprehensive session aims to equip healthcare providers with the tools and strategies needed to enhance patient care and screening outcomes.

Learning Outcomes

At the completion of this webinar, you will be able to: 

Outcome 1: Identify the rationale for, and the differences between, the program’s mail out model and the alternative access to kits model (healthcare provider issued kits)

Outcome 2: Identify the benefits of, and methods for engaging patients to participate in population screening via the alternative access to kits model

Outcome 3: Examine how to effectively use the NCSR to bulk order kits and issue them to patients

Outcome 4: Determine ways to change own practices to apply knowledge of the alternative access to kits model to help increase patient participation in population screening with the National Bowel Cancer Screening Program

Presenter Information

Professor Vivienne Milch, Medical Director at Cancer Australia

As Medical Director of Cancer Australia, I provide strategic clinical policy oversight and leadership to Cancer Australia, and advice to the Commonwealth Department of Health and Aged Care on national cancer screening policy.

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care. Our work includes the translation of evidence into policy and practice to advance patient-centred care; innovative and sustainable models of best practice cancer care and investment in priority areas of cancer research.

I am passionate about the importance of early detection of cancer, equity of access to optimal cancer care, multidisciplinary survivorship care, and improving the lives of all Australians affected by cancer.

Pre-webinar recommended learning  

Core CPD Course:  Bums on (toilet) seats: population screening for bowel cancer in Australia

Core CPD Course: From kit to colonoscopy: navigating your patients through population bowel screening

CPD

Educational activities: 1.5 hour